GlaxoSmithKline's new chairman will climb aboard months earlier than expected

GlaxoSmithKline's ($GSK) new chairman will take over several months earlier than expected. When Glaxo tapped Sir Philip Hampton, now chair of Royal Bank of Scotland, to lead its board last fall, his target start date was September of this year. But now, the drugmaker says Hampton is free to take the reins in May. Hampton replaces Christopher Gent, who's been chairman since 2005, at a time when GSK is under pressure from investors to step up its performance. Report

Suggested Articles

Former Indivior CEO Shaun Thaxter will face six months in federal prison for his role in misleading government officials on the dangers of Suboxone.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.